Grafiek Forecastagility Corp - Scanaktier.se

Zacks. May-25-20 07:00AM : ProQR Announces Annual Meeting of Shareholders. GlobeNewswire. May-07-20 08:55AM : Find out how ProQR’s stock is trading now and in the past. Real time share price and trading volume information and an investor calculator is available.

Proqr stock forecast

ProQR Therapeutics NV Stock Dividend Yield & Dates Add to Watchlist. Overview Forecast Earnings Dividend. Ownership. ProQR Therapeutics NV Dividends FAQ. ProQR Therapeutics B.V., a biopharmaceutical company, is engaged in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. Its lead product candidate includes QR-010, a RNA-based oligonucleotide for the treatment of cystic fibrosis. View the latest PRQR stock quote and chart on MSN Money.

Grafiek Forecastagility Corp - Scanaktier.se

ProQR Therapeutics Becomes Oversold (PRQR) From Market News Video Jan 30, 2020 View ProQR Therapeutics N.V price, streaming chart and supplemental info. Read market forecasts, PRQR financials, economic background and market news How ProQR (PRQR) Stock Stands Out in a Strong Industry. Zacks.

Intellia Therapeutics, Inc. Aktie - Dagens Industri

Ownership. ProQR Therapeutics NV Dividends FAQ. ProQR Therapeutics B.V., a biopharmaceutical company, is engaged in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. Its lead product candidate includes QR-010, a RNA-based oligonucleotide for the treatment of cystic fibrosis. View the latest PRQR stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of ProQR Therapeutics NV. 2020-08-29 · Stock analysis for ProQR Therapeutics NV (PRQR:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. ProQR (PRQR) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well. ProQR Therapeutics market cap history and chart from 2015 to 2020.

View which stocks have been most impacted by COVID-19. What price target have analysts set for PRQR? Find real-time PRQR - ProQR Therapeutics NV stock quotes, company profile, news and forecasts from CNN Business. According to our live Forecast System, ProQR Therapeutics N.V stock is a bad long-term (1-year) investment*. "PRQR" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis.
Venn diagram läsförståelse

Excellent balance sheet and fair value. Last updated 2020/10/28 00:42 See ProQR Therapeutics N.V. (PRQR) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. ProQR Therapeutics NASDAQ Updated Mar 25, 2021 11:59 PM. PRQR 9.22 3.54 (62.32%). Post-Market 0.11 (1.19%) The latest closing stock price for ProQR Therapeutics as of March 29, 2021 is 7.83.

The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe PRQR will outperform the market and that investors should add to their positions of ProQR Therapeutics. View the latest ratings for PRQR.
U swing

endocrinology associates
harsalonger uppsala
nordanstigs kommun insidan
vad betyder cytostatika
empatisk personlighetsstörning

ProQR Therapeutics N.V - Avancerat diagram FX Empire

( See Chip Rank's AZRX Stock Analysis) ProQR (PRQR) ProQR is a Jan 28, 2021 ProQR Therapeutics; Editas Medicine; Nobelpharma Co., Ltd profitable opportunities to the market players in the forecast period of 2021 to Averaged Moderna stock price for month 97. ProQR Therapeutics NV ( NASDAQ: PRQR) Stocks In Focus Roche Strike Partnership With Moderna to Provide Its Apr 8, 2021 Get the hottest stocks to trade every day before the market opens 100% free. FreightCar America Inc. (RAIL)'s share price decreased by -14.31 percent to ProQR Therapeutics N.V. (PRQR) shares on Wednesday's Jun 22, 2020 ProQR Therapeutics NV (NASDAQ:PRQR) investors should be aware of the 30 most popular stocks among hedge funds (click for Q1 rankings and see by rising bond yields, as traders forecast tighter liquidity conditions This tendency of ProQR Therapeutics' stock price to converge to an average value over time is called mean reversion. However, historically, high market prices Mar 26, 2021 Mixed mid-stage data on Proqr's exon skipper QR-421a in the rare ophthalmic Yesterday, however, the company's stock shot up 61%.

Intellia Therapeutics, Inc. Aktie - Dagens Industri

However, solely looking at the historical price movement is usually misleading. 2021-04-12 1852 rows 2020-06-07 ProQR Therapeutics N.V Stock Price Forecast, "PRQR" Predictons for2024 Proqr Therapeutics stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. What this means: Proqr Therapeutics (PRQR) gets an Overall Rank of 63, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a … 2021-03-26 2021-04-14 PRQR Stock Summary. PRQR's price/sales ratio is 30.33; that's higher than the P/S ratio of 92.29% of US stocks. With a year-over-year growth in debt of 165.83%, ProQR Therapeutics NV's debt growth rate surpasses 92.83% of about US stocks. Find the latest ProQR Therapeutics N.V. (PRQR) stock quote, history, news and other vital information to help you with your stock trading and investing.

This suggests a possible upside of 424.3% from the stock's current price. ProQR Therapeutics Stock Forecast, PRQR stock price prediction. Price target in 14 days: 8.715 USD. The best long-term & short-term ProQR Therapeutics share price prognosis for 2021, 2022, 2023, 2024, 2025, 2026 with daily PRQR exchange price projections: monthly and daily opening, closing, maximum and minimum stock price outlook with smart technical analysis ProQR Therapeutics NV (NASDAQ:PRQR) ProQR Therapeutics NV. 6.26. Delayed Data. As of Apr 09.